LigaChem Biosciences

141080.KQ

119.32 USD

-7.81

-6.14%

Overview

Last close

119.32 usd

Market cap

4.34B usd

52 week high

133.20 usd

52 week low

51.20 usd

Target price

123.99 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

40.2747

Price/Book Value

11.581

Enterprise Value

3.98B usd

EV/Revenue

36.8483

EV/EBITDA

5044.2569

Key financials

Revenue TTM

108.00M usd

Gross Profit TTM

97.06M usd

EBITDA TTM

-28.02M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

499.34M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.